- Sections
- C - Chimiemétallurgie
- C07C - Composés acycliques ou carbocycliques
- C07C 13/06 - Hydrocarbures monocycliques ou leurs dérivés hydrocarbonés acycliques à cycle à quatre chaînons
Détention brevets de la classe C07C 13/06
Brevets de cette classe: 28
Historique des publications depuis 10 ans
|
2
|
4
|
5
|
3
|
2
|
0
|
1
|
2
|
0
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Celgene Corporation | 1400 |
6 |
| Novaled GmbH | 465 |
4 |
| Merck Sharp & Dohme Corp. | 2186 |
3 |
| Board of Supervisors of Louisiana State University and Agricultural and Mechanical College | 826 |
2 |
| Coave Therapeutics | 13 |
2 |
| Canon Inc. | 41921 |
1 |
| Konica Minolta Business Technologies, Inc. | 1362 |
1 |
| The United States of America as represented by the Secretary of the Navy | 2818 |
1 |
| The Board of Trustees of the Leland Stanford Junior University | 6597 |
1 |
| InterMune, Inc. | 49 |
1 |
| NUtech Ventures | 350 |
1 |
| The Research Foundation for The State University of New York | 1699 |
1 |
| Stockton (Israel) Ltd. | 38 |
1 |
| The University of Melbourne | 558 |
1 |
| Ferox Therapeutics LLC | 1 |
1 |
| Merck Sharp & Dohme LLC | 3719 |
1 |
| Autres propriétaires | 0 |